GlobalData’s new report, "Asia-Pacific Biopsy Procedures Outlook to 2023", provides key procedures data on the Asia-Pacific Biopsy Procedures. The report provides procedure volumes within market segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
- Asia-Pacific Biopsy Procedures volumes by segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures. - Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
Reasons to Buy
- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future. - Develop market-entry and market expansion strategies.
Our reports have been used by over 10K customers, including:
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. - According to the Centers for Disease Control and Prevention (CDC) reports,...
275 pages •
By Global Industry Analysts
• Apr 2021
- Global Hepatitis Test Solution/Diagnosis Market to Reach $3.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Hepatitis Test Solution/Diagnosis estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 4.7% over...
The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2020 to 2028. Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics...
The global SIBO diagnostics market is expected to reach US$ 194,604.51 thousand by 2028 from US$ 138,324.23 thousand in 2020. It is estimated to grow at a CAGR of 4.4% from 2021 to 2028. Initially, jejunal aspiration and duodenal fluid analyses were used to diagnose SIBO.Due to the invasiveness of jejunal aspirates’ and duodenal fluids...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the clinical oncology next generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The global clinical oncology next generation sequencing...
The global AI in medical diagnostics market is projected to reach USD 3,868 million by 2025 from USD 505 million in 2020, at a CAGR of 50.2% during the forecast period. Growth in this market is primarily driven by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field,...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
2021 Food Diagnostics Systems Market - Size, Share, COVID Impact Analysis and Forecast to 2027 2021 Food Diagnostics Systems Market - Size, Share, COVID Impact Analysis and Forecast to 2027 – is comprehensive research with in-depth data and contemporary analysis of Food Diagnostics Systems Market at a global, regional...
Prostate Cancer Diagnostics and Therapy Market Report Overview Prostate Cancer Diagnostics and Therapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Prostate Cancer Diagnostics and Therapy market types and applications. It is a focused...
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.